Manchester, CT, United States of America

Stephanie Reeve

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Connecticut. Active years: 2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stephanie Reeve: Innovator in Antifolate Research

Introduction

Stephanie Reeve is a notable inventor based in Manchester, Connecticut. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for treating bacterial infections. Her innovative work has led to the granting of a patent that showcases her expertise and dedication to improving healthcare.

Latest Patents

Stephanie Reeve holds a patent for "Zwitterionic propargyl-linked antifolates useful for treating bacterial infections." This patent discloses compounds of a specific formula and their pharmaceutically acceptable salts. The invention includes pharmaceutical compositions that comprise these compounds and methods for inhibiting dihydrofolate reductase (DHFR) in vitro or in vivo. Additionally, it outlines methods for treating bacterial, fungal, and protozoal infections using these compounds. This patent highlights her innovative approach to addressing critical health challenges.

Career Highlights

Stephanie Reeve is affiliated with the University of Connecticut, where she continues her research and development efforts. Her work has not only contributed to her field but has also paved the way for future innovations in pharmaceutical treatments. With a focus on creating effective solutions for infections, she has established herself as a key figure in her area of expertise.

Collaborations

Throughout her career, Stephanie has collaborated with esteemed colleagues, including Santosh Keshipeddy and Michael N Lombardo. These partnerships have enhanced her research and contributed to the successful development of her patented inventions.

Conclusion

Stephanie Reeve's contributions to the field of pharmaceutical sciences are commendable. Her innovative patent for zwitterionic propargyl-linked antifolates demonstrates her commitment to advancing healthcare solutions. Through her work at the University of Connecticut and collaborations with fellow researchers, she continues to make a significant impact in the fight against infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…